Cutaneous Anaplastic Large Cell Lymphoma in a Multiple Sclerosis Patient Receiving Fingolimod Publisher Pubmed



Manouchehri N^{1, 2} ; Mirmosayyeb O^{1, 2} ; Badihian S^{1, 2} ; Shaygannejad V^{1, 3}
Source: Multiple Sclerosis and Related Disorders Published:2018

Abstract

Background Previous reports of cutaneous neoplastic lesions secondary to Fingolimod treatment among multiple sclerosis patients. Objective Reporting a case of cutaneous large cell lymphoma in a multiple sclerosis patient during Fingolimod treatment. Method Case study. Result Our patient developed CD30+ cutaneous large cell lymphoma two years after initiation of Fingolimod treatment and her symptoms regressed following the cessation of treatment. Conclusion This report indicates that cutaneous lymphoid neoplasms should be considered a possible side effect among patients receiving Fingolimod. © 2017 Elsevier B.V.